NewAmsterdam Pharma Company N.V.

NasdaqGM:NAMS

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Pharmaceuticals

💉 Vaccines

Location

Netherlands

Market Cap

USD 2.65 B

Share Price

USD 23.60

Avg Daily Volume

799,776

Change (1 day)

0.90%

Change (1 year)

26.07%

Change (YTD)

-8.17%

NewAmsterdam Pharma Company N.V. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending December 31, 2024: -45.13%

NewAmsterdam Pharma Company N.V. Return on Assets (ROA) is -45.13% for the Trailing 12 Months (TTM) ending December 31, 2024. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Competitors

AbbVie Inc.

USD 190.28

ABBV

-0.55 -0.29%

Novo Nordisk A/S

USD 70.93

NOVO-B.CO

+0.75 1.07%

Roche Holding AG

USD 345.06

RO.SW

-6.70 -1.91%

Novartis AG

USD 116.76

NOVN.SW

-0.57 -0.49%

AstraZeneca PLC

USD 145.14

AZN.L

-2.14 -1.46%

Abbott Laboratories

USD 126.54

ABT

+0.90 0.72%

Merck & Co., Inc.

USD 84.71

MRK

+0.60 0.71%

Amgen Inc.

USD 306.58

AMGN

-1.97 -0.64%

Pfizer Inc.

USD 24.79

PFE

-0.56 -2.21%

Gilead Sciences, Inc.

USD 116.20

GILD

+3.00 2.65%

Sanofi

USD 99.93

SAN.PA

-0.18 -0.18%

Vertex Pharmaceuticals Incorporated

USD 469.65

VRTX

-2.62 -0.56%

Bristol-Myers Squibb Company

USD 48.43

BMY

-0.51 -1.04%

CSL Limited

USD 175.87

CSL.AX

-1.75 -0.98%

Chugai Pharmaceutical Co., Ltd.

USD 49.71

4519.T

+0.51 1.03%

View all

Key Data

Date	Return on Assets (ROA)	Revenue Per Share	Free Cash Flow Per Share	Dividend Per Share